Aurora Cannabis (ACB) Change in Working Capital (2018 - 2025)
Aurora Cannabis (ACB) reported Change in Working Capital of $215.1 million for Q4 2025, down 37.56% year-over-year from $344.4 million in Q4 2024, and down 1.26% quarter-over-quarter from $217.8 million in Q3 2025.
Aurora Cannabis (ACB) Change in Working Capital (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Change in Working Capital data on file, last reported at $215.1 million in Q4 2025.
- Change in Working Capital for Q4 2025 came in at $215.1 million, down 37.56% year-over-year; the trailing twelve-month figure through Dec 2025 was $215.1 million (down 37.56% YoY), and the FY2025 annual result was $256.1 million, down 15.2% from the prior year.
- Change in Working Capital fell to $215.1 million in Q4 2025 per ACB's latest filing, from $217.8 million in the prior quarter.
- Over five years, Change in Working Capital peaked at $646.3 million in Q3 2021 and troughed at -$21.7 million in Q3 2024.
- A 5-year average of $211.8 million and a median of $210.7 million in 2021 frame the typical range for Change in Working Capital.
- The sharpest annual moves came in 2023 and 2025: Change in Working Capital slumped 253.86% in 2023, then surged 2750.02% in 2025.
- A 5-year view of Change in Working Capital shows it stood at $549.5 million in 2021, then slumped by 103.4% to -$18.7 million in 2022, then jumped by 1700.47% to $299.2 million in 2023, then advanced by 15.13% to $344.4 million in 2024, then slumped by 37.56% to $215.1 million in 2025.
- Business Quant data shows ACB's Change in Working Capital at $215.1 million in Q4 2025, $217.8 million in Q3 2025, and $222.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 215.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 215.05 Mn |
| Dec 31, 2025 | 215.05 Mn |
| Sep 30, 2025 | 217.79 Mn |
| Sep 30, 2025 | 217.79 Mn |
| Jun 30, 2025 | 222.59 Mn |
| Jun 30, 2025 | 222.59 Mn |
| Mar 31, 2025 | -4.95 Mn |
| Mar 31, 2025 | -4.95 Mn |
| Dec 31, 2024 | 344.40 Mn |
| Dec 31, 2024 | 344.40 Mn |
| Sep 30, 2024 | -21.69 Mn |
| Sep 30, 2024 | -21.69 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Jun 30, 2024 | 7.81 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Mar 31, 2024 | 15.40 Mn |
| Dec 31, 2023 | 299.15 Mn |
| Dec 31, 2023 | 299.15 Mn |
| Sep 30, 2023 | -11.03 Mn |
| Sep 30, 2023 | -11.03 Mn |